Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6539290

O=C(Nc1ccc(C[C@@H](CO)NC[C@H](O)COc2ccccc2)cc1)Nc1ccc([N+](=O)[O-])cc1.O=C(O)C(F)(F)F

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 16/20 0.79
ADRB1 P08588 14/20 0.79
ALDH1A1 P00352 1/20 0.58
PKM P14618 1/20 0.58
MAPK1 P28482 1/20 0.58
ADRB2 P07550 2/20 0.53
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6539793 0.93 ADRB3 (0.92) ADRB3ADRB1ALDH1A1PKMMAPK1
Trifluoroacetic Acid SCHEMBL6539368 0.90 ADRB3 (0.70) ADRB3ADRB1ALDH1A1PKMMAPK1
Trifluoroacetic Acid SCHEMBL6539537 0.88 ADRB3 (0.81) ADRB3ADRB1ADRB2MEN1KMT2A
SCHEMBL6539169 0.88 ADRB1 (0.72) ADRB3ADRB1ALDH1A1PKMMAPK1
Trifluoroacetic Acid SCHEMBL6539502 0.88 ADRB3 (0.80) ADRB3ADRB1ALDH1A1ADRB2MEN1
Trifluoroacetic Acid SCHEMBL6538892 0.87 ADRB3 (0.79) ADRB3ADRB1ADRB2MAPT
SCHEMBL6538626 0.86 ADRB3 (1.00) ADRB3ADRB1ALDH1A1PKMMAPK1
SCHEMBL6539300 0.86 ADRB3 (0.61) ADRB3ADRB1ALDH1A1PKMMAPK1
Trifluoroacetic Acid SCHEMBL6538830 0.85 ADRB3 (0.76) ADRB3ADRB1ADRB2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6539378 0.85 ADRB3 (0.76) ADRB3ADRB1PKMMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed